1. Wang YJ, Shahrokh Z, Vemuri S, Eberlein G, Beylin I, Busch M. Characterization, stability, and formulations of basic fibroblast growth factor. Chapter 2 in Pearlman R, Wang YJ, editors. Pharmaceutical Biotechnology, Vol. 9, Formulation, characterization, and stability of protein drugs: case histories. Plenum, New York, 1996
2. Haraguchi T, Okada K, Tabata Y, Maniwa Y, Hayashi Y, Okita Y. Controlled release of basic fibroblast growth factor from gelatin hydrogel sheet improves structural and physiological properties of vein graft in rat. Arterioscl Throm Vas. 2007;27:548–55.
3. Volkin DB, Middaugh CR. The characterization, stabilization, and formulation of acidic fibroblast growth factor. Chapter 3 in Pearlman R, Wang YJ, editors. Pharmaceutical Biotechnology, Vol. 9, Formulation, characterization, and stability of protein drugs: case histories. Plenum, New York, 1996
4. Cho Lee AR, Leem H, Lee J, Park KC. Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. Biomaterials. 2005;26:4670–6.
5. Grzybowski J, Oldak E, Antos-Bielska M, Janiak MK, Pojda Z. New cytokine dressings. I. Kinetics of the in vitro rhG-CSF, rhGM-CSF, and rhEGF release from the dressings. Int J Pharm. 1999;184:173–8.